Drug-associated diarrhoea and constipation in older people: 2. Constipation

Australian Journal of Hospital Pharmacy

Volumn 30, Issue 5, 2000, Pages 210-213

  Ratnaike, Ranjit N ^a   Milton, Austin G ^a   Nigro, Olimpia ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; AMITRIPTYLINE; ANTIDIARRHEAL AGENT; ANTIHYPERTENSIVE AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CALCIUM DERIVATIVE; CLONAZEPAM; CLONIDINE; CLOZAPINE; CODEINE; COLCHICINE; DICYCLOVERINE; FENTANYL; IMIPRAMINE; LAXATIVE; METHYLDOPA; MISOPROSTOL; MORPHINE; NALOXONE; NEUROLEPTIC AGENT; OPIATE AGONIST; OXYCODONE; PETHIDINE; PHENYTOIN; PROPRANOLOL; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

AGING; CONFUSION; CONSTIPATION; DIARRHEA; DOSE RESPONSE; EXERCISE; FECES IMPACTION; GERIATRIC PATIENT; HIGH FIBER DIET; HUMAN; QUALITY OF LIFE; SHORT SURVEY;

EID: 0033762453     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2000305210     Document Type: Short Survey

References (30)

1. Woodward MC. Constipation: aetiology and diagnosis. In: Ratnaike RN, editor. Diarrhoea and constipation in geriatric practice. London: Cambridge University Press; 1999: 187-93.
2. Whitehead WE, Drinkwater D, Cheskin LJ, Heller BR, Schuster MM. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc 1989; 37: 423-9.
3. Harari D, Gurwitz JH, Minaker KL. Constipation in the elderly. J Am Geriatr Soc 1993; 41: 1130-40.
4. Wald A. Constipation and fecal incontinence in the elderly. Gastroenterol Clin North Am 1990; 19: 405-18.
5. Melkersson M, Andersson H, Bosaeus I, Falkheden T. Intestinal transit time in constipated and nonconstipated patients. Scand J Gastroenterol 1983; 18: 593-7.
6. Ratnaike RN, Milton AG, Nigro O. Drug-associated diarrhoea and constipation in older people. I. Diarrhoea. Aust J Hosp Pharm 2000; 30: 165-9.
7. Peterson G. Geriatrics. In: Hughes J, Donnelly R, James-Chatgilaou G, editors. Clinical pharmacy - a practical approach. Melbourne: The Society of Hospital Pharmacists of Australia. MacMillan Education Australia Pty. Ltd.; 1998: 50-6.
8. Parfitt K, editor. Martindale - the complete drug reference. 32nd ed. London: Pharmaceutical Press; 1999: 57.
9. Woodhouse KW, James OFW. Hepatic drug metabolism and ageing. Br Med Bull 1990; 46: 22-35.
10. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly [review]. Drugs Aging 1999; 15: 15-28.
11. Yuan CS, Foss JF, O'Connor M, Moss J, Roizen MF. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol 1998; 38: 931-5.
12. DeLuca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996; 69: 103-15.
13. Culpepper-Morgan JA, Inturrisi CE, Portenoy RK, Foley K, Houde RW, Marsh F, et al. Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther 1992; 52: 90-5.
14. Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill; 1996.
15. Hayes G, Gibler B. Clozapine-induced constipation [letter]. Am J Psychiatry 1995; 152: 298.
16. Adverse Drug Reactions Advisory Committee (ADRAC). Constipation - it can be severe with clozapine. Australian Adverse Drug Reactions Bulletin 1999; 18: 14.
17. Krevsky B, Maurer AH, Niewiarowski T, Cohen S. Effect of verapamil on human intestinal transit. Dig Dis Sci 1992; 37: 919-24.
18. Jackson DV, Wells HB, Atkins JN, Zekan PJ, White DR, Richards F 2d, et al. Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 1988; 84: 1016-22.
19. Johnston CF, Shaw C, Buchanan KD. Vincristine-induced abnormalities of gastrointestinal regulatory peptide cells of the rat. An immunocytochemical study. Cell Tissue Res 1985; 239: 229-33.
20. Parfitt K, editor. Martindale - the complete drug reference, 32nd ed. London: Pharmaceutical Press; 1999: 1177-8.
21. Thompson WG. Laxatives: clinical pharmacology and rational use. Drugs 1980; 19: 49-58.
22. Mykyta LJ. Faecal incontinence. In: Ratnaike RN, editor. Diarrhoea and constipation in geriatric practice. London: Cambridge University Press, 1999: 70-8.
23. Tobin GW, Brocklehurst JC. Faecal incontinence in residential homes for the elderly: prevalence, aetiology and management. Age Ageing 1986; 15: 41-6.
24. Wright BA, Staats DO. The geriatric implications of fecal impaction. Nurse Pract 1986; 11: 53-8, 60, 64-6.
25. Silver AJ. Aging and risks for dehydration. Cleve Clin J Med 1990; 57: 341-4.
26. Verne NG, Eaker EY, Davis RH, Sninsky CA. Colchicine is an effective treatment for patients with chronic constipation: an open-label trial. Dig Dis Sci 1997; 42: 1959-63.
27. Mullins ME, Carrico EA, Horowitz BZ. Fatal cardiovascular collapse following acute colchicine ingestion. J Toxicol Clin Toxicol 2000; 38: 51-4.
28. Soffer EE, Launspach J. Effect of misoprostol on postprandial intestinal motility and orocecal transit time in humans. Dig Dis Sci 1993; 38: 851-5.
29. Won-Kim S, Kachur JF, Gaginella TS. Stereospecific actions of misoprostol on colonie electrolyte transport. Prostaglandins 1993; 46: 221-31.
30. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116-52.